Basic Information
Basic information for MIR9-3HG-219-12aa-2
Peptide Name MIR9-3HG-219-12aa-2
Genome Position chr15:89397003-89397038[+]
Species Human
Peptide Sequence MSFFQLHQIERG
Peptide Length 12
Unique No (MIR9-3HG-201-12aa,MIR9-3HG-212-12aa,MIR9-3HG-213-12aa-2,MIR9-3HG-214-12aa-1,MIR9-3HG-218-12aa-1,MIR9-3HG-220-12aa,MIR9-3HG-221-12aa,MIR9-3HG-222-12aa,MIR9-3HG-226-12aa-1,MIR9-3HG-227-12aa-1,MIR9-3HG-233-12aa,MIR9-3HG-241-12aa,MIR9-3HG-246-12aa,MIR9-3HG-247-12aa,MIR9-3HG-251-12aa,MIR9-3HG-252-12aa-1,MIR9-3HG-253-12aa)
Grand Average of Hydropathicity -0.3
Relative Molecular Mass 1690.88
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000255571;MIR9-3HG
Transcript ID/Name ENST00000658194;MIR9-3HG-219
Transcript Length 4266
Coding Ability 0.4834
DNA Sequence Corresponding to Peptide ATGTCATTTTTCCAGTTGCACCAAATCGAAAGAGGT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :